跳转至内容
Merck
CN
  • Core 1-derived mucin-type O-glycosylation protects against spontaneous gastritis and gastric cancer.

Core 1-derived mucin-type O-glycosylation protects against spontaneous gastritis and gastric cancer.

The Journal of experimental medicine (2019-10-28)
Fei Liu, Jianxin Fu, Kirk Bergstrom, Xindi Shan, J Michael McDaniel, Samuel McGee, Xia Bai, Weichang Chen, Lijun Xia
摘要

Core 1-derived mucin-type O-glycans (O-glycans) are a major component of gastric mucus with an unclear role. To address this, we generated mice lacking gastric epithelial O-glycans (GEC C1galt1-/-). GEC C1galt1-/- mice exhibited spontaneous gastritis that progressed to adenocarcinoma with ∼80% penetrance by 1 yr. GEC C1galt1-/- gastric epithelium exhibited defective expression of a major mucus forming O-glycoprotein Muc5AC relative to WT controls, which was associated with impaired gastric acid homeostasis. Inflammation and tumorigenesis in GEC C1galt1-/- stomach were concurrent with activation of caspases 1 and 11 (Casp1/11)-dependent inflammasome. GEC C1galt1-/- mice genetically lacking Casp1/11 had reduced gastritis and gastric cancer progression. Notably, expression of Tn antigen, a truncated form of O-glycan, and CASP1 activation was associated with tumor progression in gastric cancer patients. These results reveal a critical role of O-glycosylation in gastric homeostasis and the protection of the gastric mucosa from Casp1-mediated gastric inflammation and cancer.

材料
货号
品牌
产品描述

Sigma-Aldrich
Anti-CASP1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution